Navigation Links
RCOG Completes Successful Atlanta Community Prostate Cancer Screening
Date:2/9/2009

For one week in January Radiotherapy Clinics of Georgia (rcog.com) and NewsTalk 750 WSB teamed up to promote prostate cancer educational outreach. Called the 'Prostate Proactivity Campaign,' the effort helped screen over 1,700 men throughout metro Atlanta with potential life-saving full prostate cancer screenings at no cost. Atlanta is the home of RCOG, the only source for the ProstRcision cancer treatment procedure. ProstRcision (prostrcision.com) has the highest documented prostate cancer cure rate in the world.

Atlanta, GA (PRWEB) February 9, 2009 -- Radiotherapy Clinics of Georgia (rcog.com) is proud to announce the successful full prostate screening of over 1,700 men throughout metro Atlanta. Called the "Prostate Proactivity Campaign," the potentially life-saving prostate cancer screening was provided by a joint educational outreach effort by Radiotherapy Clinics of Georgia (RCOG) and NewsTalk 750 WSB.

Combating the Second Leading Cause of Cancer Death in American Men:
According to the American Cancer Society, prostate cancer is the second leading cause of cancer death in American men--one in six men will be diagnosed with prostate cancer in his lifetime. If detected early and combined with proper prostate cancer treatment the cure rate is nearly 100 percent.

Full Screenings at No Cost:
Mobile testing units were dispatched to Atlanta, Cumming, Snellville, Covington, Buford and Kennesaw during the week with the help of Zero (zerocancer.org). The mobile team provided full prostate screenings, including DRE and PSA tests. PSA tests were sent to the University of Michigan for analysis and the men participating in the screening were notified of the results. In addition to the screenings, information about prostate health was provided at all locations.

John Critz, Vice President of Marketing for RCOG explains, "We are thrilled with the Atlanta-area's community response to the screenings. Last year we screened just over 1,000 men, and this year to screen over 1,700 speaks to is truly a testament to the growing awareness of the prevalence of prostate cancer. The most important thing we at Radiotherapy Clinics of Georgia want men to know about prostate cancer is that it is highly curable -- If it is detected early, and regular screening is the key to early diagnosis.
Importance of Screenings:

Prostate cancer can be detected through a PSA test. This test is a simple blood test that determines the level of prostate-specific antigen levels in the body. It is recommended men 50 years of age and older are screened annually for prostate cancer. African-American men and men with a family history of prostate cancer are advised to be testing at age 40, as they are at a higher risk to develop prostate cancer. Depending on the results from this test, men may be referred for a biopsy of the prostate.

The Only Source for ProstRcision:
Radiotherapy Clinics of Georgia, based in metro Atlanta, is the only source for ProstRcision. ProstRcision is a prostate cancer radiation therapy procedure that boasts an 83% overall cure rate using the absolute strictest definition of cure, the highest documented cure rate in the world for prostate cancer. Each year hundreds of patients from across the country and throughout the world travel to Georgia to seeking cure of their prostate cancer by the ProstRcision procedure. ProstRcision is also the preferred treatment method for many men because of the lower incidences of side effects, particularly incontinence and impotence, relative to other treatment procedures.

If you have questions about prostate cancer, or to learn more about the differences between ProstRcision at Radiotherapy Clinics of Georgia and prostate cancer surgery, including robotic radical prostatectomy, visit RCOG.com and ProstRcision.com or call 1-800-952-7687.

About Radiotherapy Clinics of Georgia
Radiotherapy Clinics of Georgia is a Center of Excellence for prostate cancer treatment and research. Each year hundreds of men travel to receive prostate cancer treatment in Atlanta, Georgia from RCOG. RCOG is one of the oldest prostate seed implant programs in the world. The first prostate implant for prostate cancer at RCOG was performed in 1977, and the first patient was treated with the combination therapy now called ProstRcision in 1979. Dr. Frank Critz, founder and medical director of RCOG, developed the ProstRcision procedure and has treated more than 8,000 patients with the disease in the past 25 years. RCOG is the only source for ProstRcision, in which two forms of radiation therapy are used to destroy the prostate gland. To date, nearly 12,000 men have received treatment with ProstRcision at RCOG's seven Metro Atlanta clinics. To learn more, please visit rcog.com.

###

Read the full story at http://www.prweb.com/releases/prostate-cancer-screening/newstalk-750-wsb/prweb1971764.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. CDS Completes Large-Scale Transition of Medicare Data Processing
2. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
3. C8 Science Panel Completes Uric Acid Study
4. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
5. Johnson & Johnson Completes Acquisition of Mentor Corporation
6. Johnson & Johnson Completes Tender Offer for Mentor Corporation
7. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
8. Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered
9. InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
10. InSet Technologies Completes $25 Million Financing
11. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
RCOG Completes Successful Atlanta Community Prostate Cancer Screening
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth ... incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially higher ... make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, “the ...
(Date:2/8/2016)... Las Vegas, Nevada (PRWEB) , ... February 08, ... ... Co-Founder at RowdMap, Inc., will be speaking on how healthcare companies can use ... project costs, manage the health of a population and intervene and capture the ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by ... require dental technicians to be certified or obtain continuing education. To increase patient ... “What’s In Your Mouth?” campaign to inform dentists and patients about the possible ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... ... US Sports Camps is proud to sponsor the Bay Area Disc Association's ... leaders, ultimate organizations, and coaches from around the US. The theme for this year’s ... of Youth and Education, describes this year YUCC as “an important conversation we must ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DURHAM, N.C. , Feb. 8, 2016  Avista ... appointed Eric Setzer as Chief Financial Officer (CFO). ... over twenty years of experience in various roles within ... Avista Pharma, he served as the Executive Director of ... organization in Raleigh, NC . Previously, ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... 2016 Palatin Technologies, Inc. (NYSE MKT: ... therapeutics for the treatment of diseases with significant ... that the United States Patent and Trademark Office ... U.S. Patent Application Serial Number 14/313,258 (the ,258 ... treating female sexual dysfunction using the formulation and ...
Breaking Medicine Technology: